Li Kang Biomedical Co Stock

Li Kang Biomedical Co P/B

The P/B (Price-to-Book Ratio) of Li Kang Biomedical Co (6242.TWO) as of Aug 8, 2026 is 1.40. In the previous year, P/B (Price-to-Book Ratio) was 1.42 — a change of -1.79% (lower).

P/B

1.40

YoY

-1.79%

Last updated:

P/B (Price-to-Book Ratio) of Li Kang Biomedical Co is 2026 1.40 . P/B (Price-to-Book Ratio) of Li Kang Biomedical Co was 2025 1.42 . It decreases by -1.79% lower compared to the previous year.
Access this data via the Eulerpool API

Li Kang Biomedical Co Stock analysis

What does Li Kang Biomedical Co do? Li Kang Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Li Kang Biomedical Co stock

P/B (Price-to-Book Ratio) of Li Kang Biomedical Co is 1.40 in 2026.

P/B (Price-to-Book Ratio) of Li Kang Biomedical Co changed from 1.42 to 1.40, representing a -1.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Li Kang Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Li Kang Biomedical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Li Kang Biomedical Co

All Key Metrics — Li Kang Biomedical Co